Ribonucleotide reductase, a novel drug target for gonorrhea is a research paper published in eLife (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 097753
Lead optimisation and development of novel bacterial DNA synthesis inhibitors for the treatment of nosocomial infections caused by multi-drug resistant Gram negative-bacteria
National Institutes of Health
Grant: GM126982
National Institutes of Health
Grant: GM007287
National Science Foundation
Grant: 2017246757
National Institutes of Health
Grant: GM29595
National Institutes of Health
Grant: GM047274 in Nocera lab
National Institutes of Health
Grant: 1R35GM126982-01
Metalloenzyme structure, function and assembly
National Institutes of Health
Grant: 2R01GM029595-20
MECHANISM AND INHIBITION OF RIBONUCLEOTIDE REDUCTASES
National Institutes of Health
Grant: 5T32GM007287-12
PRE-DOCTORAL TRAINING IN THE BIOLOGICAL SCIENCES
Wellcome Trust
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01GM047274-23
Proton-Coupled Electron Transfer in Biomimetic and Natural Systems
FWCI
1.63
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals